Outsourcing channel feed – Endpoints News

SIGN UP

Outsourcing channel feed

West Pharma loses two glucose device clients but is buoyed by its GLP-1 packaging services

2 months ago

Charles River to shut down North Carolina pathology facility, says it's not a 'strategic fit'

2 months ago

Charles River to close ‘15 smaller sites’ as demand for early research declines

5 months ago

Icon's quarterly earnings hit by biotech and pharma pullback

5 months ago

Avantor sells off CRO for $650M to private equity firm

8 months ago

‘Search mode’: Human challenge trial company looks to buy small CROs

9 months ago

As confidence falls, biopharma companies take precautions with Chinese partnerships, survey finds

9 months ago

FDA to pharma companies: Using CRO Synapse's studies 'unacceptable'

10 months ago

NewVale unveils $167M fund to back pharma service providers and 'old ideas that are working'

11 months ago

Thermo Fisher downsized by 8,000 workers in 2023 amid revenue decline

Last year

CRO Fortrea 'disputes the accuracy' of Acelyrin's claims about immunology drug trial conduct

Last year

Danaher’s third-quarter revenue from biotech services down 19% amid slowdown in China, US

Last year

Thermo Fisher reels in proteomics company Olink in $3.1B deal

Last year

Looking for an edge in a competitive market, Oxford Nanopore moves into mRNA vaccine testing

Last year

Updated: As sales continue to slide, Catalent reaches deal with activist to add board seats and conduct review

Last year

CRO Syneos Health didn't hold up its end of the deal in enrollment for FSD Pharma's trial, arbitration panel finds

Last year

WuXi Biologics seeks spinout, HK listing of bioconjugates-focused joint venture

Last year

CVS will shut down clinical trials unit that it launched during Covid

Last year

CRO deal space continues to buzz as Genesis Drug Discovery buys JSS Medical Research

Last year

CRO Syneos Health to be acquired by a group of private equity firms for $7B+

Last year

On heels of Essex deal, CRO Emmes says it's planning to make more acquisitions this year

Last year

TandemAI raises $35M in Series A for small molecule discovery, wet labs

3 years ago

Pfizer was warned of Lyme study problems months ago, trial research startup's CEO tells employees

3 years ago

Flagship company teams up with Charles River for AI drug discovery

3 years ago

12 3 4 Next page Last page